|Basic InformationMore InformationLatest News|College Women More Prone to Problem Drinking Than Men: StudyIs Menopause Overlooked in U.S. Medical Schools?Young Women Less Healthy Than Men Before Heart Attack: StudyCombo Drug Therapy May Work Best to Strengthen Bones: StudyHealth Tip: Manage Menopause'Eating More Protein' Strategy Helps Women Lose WeightJust How Might Exercise Lower Breast Cancer Risk?Can High-Protein, Low-Carb Diet Boost Fertility Treatment?Potentially Toxic Metals Present in Lip CosmeticsLow-Dose 'Pill' Linked to Pain During Orgasm, Study FindsExercise May Lower Older Women's Risk for Kidney StonesNearly One-Third Don't Pick Up New Osteoporosis RxWhite House to Challenge Ruling on Unlimited Access to 'Morning-After' PillLipsticks, Glosses Contain Toxic Metals: ReportFDA Approves 'Morning-After' Pill Without a PrescriptionImplants May Delay Breast Cancer Detection, Raise Death RiskKeep Beauty Regimen Safe During Pregnancy, Doctor AdvisesPediatrician Group Issues Home Birth Policy StatementEven Light Smoking Increases Risk of RA Among WomenMammo Rates Unchanged Despite Controversial GuidelinesFamily Doc Counseling Fails to Lift QoL for Abused WomenEndometriosis Surgery Linked to Lower Ovarian Cancer RiskLaparoscopic Hysterectomy Rates on Rise Over Past DecadeMenopause-Like Woes Hinder Breast Cancer Treatment: StudyAACR: Exercise Tied to Reduced Estrogens Post-MenopauseNew Clues to How Exercise May Reduce Breast Cancer RiskDoctors Too Pap-Happy, Survey SuggestsFor Older Women, Missed Mammograms Tied to Worse Breast Cancer OutcomesExperimental Vaccine Shows Promise for Ovarian CancerFederal Judge Rules FDA Must Lift Restrictions on Plan BJudge: Make Morning-After Pill Available to All FemalesStudy Pinpoints Women at Risk for Blood Clots From PregnancyBreast Cancer Gene Tests Won't Help Most Women: ReportPhysical Activity Improves Sleep for Menopausal WomenMore Evidence Shows Hormone Therapy May Increase Breast Cancer RiskArtificial Ovaries Could Potentially Deliver Hormone TherapyNew Method May Help Pinpoint Woman's Final Menstrual PeriodHormone Pills in Menopause May Carry Gallstone Side EffectsFalse-Positive Mammograms Can Trigger Long-Term DistressData Insufficient to Link Declines in Breast Cancer, HRT UseMammograms Every Other Year OK for Women Over 50: StudyAbout 14 Percent of Moms Face Postpartum DepressionHigh-Fat Dairy Linked to All-Cause, Breast Cancer MortalityRobotic Surgery for Hysterectomy Often Not Best Option, Ob/Gyn Group SaysNight Shift Linked to Raised Risk of Ovarian CancerDNA Test Shows Promise in Guiding Advanced Breast Cancer CareObese New Mothers May Have Higher Heart Attack, Stroke RiskNew Pap Guidelines May Miss Aggressive Cancer in Young Women: StudyNonheme Iron Intake Linked to Reduced Risk of PMSMotherhood May Spur Obsessive-Compulsive Behavior in SomeQuestions and AnswersLinksBook Reviews
HRT Update: Therapy May Reduce Fractures, Boost Some Risks
by By Kathleen DohenyHealthDay Reporter
Updated: May 28th 2012
MONDAY, May 28 (HealthDay News) -- Updated evidence on hormone replacement therapy for menopausal women presents good news for those at risk of osteoporosis, but a mixed bag of results regarding breast cancer and other chronic diseases.
While estrogen-only and estrogen-plus-progestin formulations reduce the risk of fractures, both increase the odds for stroke and other conditions including gallbladder disease, according to a new update of available evidence compiled for the U.S. Preventive Services Task Force, an independent expert panel that is revising its guidelines.
Estrogen-plus-progestin therapy raises the risk of breast cancer and probable dementia, while estrogen alone reduces the risk of breast cancer, the researchers found.
"We looked at all the published studies on hormone therapy for the prevention of chronic disease," said Dr. Heidi Nelson, who led the update. "What is new here is, we've taken all the results from the last 10 years and tried to distill them into the latest, most current results and how they might apply to individuals."
Some protective effects found in earlier research now appear weaker, added Nelson, a professor of medical informatics, clinical epidemiology and medicine at the Oregon Health & Science University, in Portland. Similarly, some risks look even stronger.
The findings are published online May 29 in the Annals of Internal Medicine.
Years ago, hormone therapy was often prescribed to prevent chronic conditions such as osteoporosis and cardiovascular disease. But initial results of the Women's Health Initiative study, published in 2002, found harmful effects for estrogen-plus-progestin regimens. Two years later, serious alarms were raised about estrogen-only therapy.
As a result, the task force recommended against both types of treatment for prevention of chronic disease.
Now, with about 11 years of follow-up to the Women's Health Initiative, researchers have a fuller picture, which the task force will use to update its existing guidelines.
The recommendations concern only chronic disease, not the use of hormone therapy for reducing symptoms of menopause, such as hot flashes.
For the update, Nelson and her team looked at 51 published articles, involving nine research trials, that met their criteria.
They confirmed that both estrogen alone and combination therapy reduce the risk of fractures, as found before. But they concluded that both types of treatment increase the risk of stroke, blood clots, gallbladder disease and urinary incontinence.
While estrogen alone seems to reduces the risk of breast cancer, they found stronger evidence than before that combination therapy increases the risk for breast cancer. For every 10,000 women, eight more cases of breast cancer per year are expected in those on combination therapy, Nelson said.
Women who smoke, used birth control pills or took combination therapy for symptoms of menopause have higher risks of breast cancer, they found.
Estrogen-only therapy appears to reduce invasive breast cancer by about the same amount, she said, but cautioned that it's not a reason for taking it. This effect is stronger than before, Nelson said.
Other changes: Initial results indicated that those on combination therapy had a significant increased risk for heart disease. Now, that association appears weaker, she said.
Previously, the estrogen-progestin combination was thought to protect against colon cancer. That link also looks weaker, she said.
Nelson said the differences in risks and benefits are probably explained more by the risk profiles of the women who take each therapy rather than the progestin or its lack in the therapy itself. The women have different risk factors to begin with, she said. For instance, many taking only estrogen have had a hysterectomy, with their uterus and ovaries removed, she said.
Bottom line? It does not appear wise to take hormone therapy long-term to prevent chronic conditions, she said. The best strategy remains to take the therapy, if needed for symptoms, at the lowest dose for the shortest time possible.
Given the different risks associated with estrogen-only and combination therapy, it's important to discuss your individual health history with your doctor, experts said.
Dr. Jill Rabin, chief of ambulatory care, obstetrics and gynecology at Long Island Jewish Medical Center, in New Hyde Park, N.Y., agreed that short-term, low-dose therapy for relief of symptoms is the best strategy.
Another option, she tells her patients, is to "think local." Some women are helped by estrogen cream or estrogen vaginal rings, she said.
To learn more about hormone therapy, visit the U.S. National Institutes of Health.
This article: Copyright © 2012 HealthDay. All rights reserved.